BeiGene Ltd. ADR (NASDAQ: ONC) on Friday, plunged -9.76% from the previous trading day, before settling in for the closing price of $264.32. Within the past 52 weeks, ONC’s price has moved between $126.97 and $287.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 80.39%. The company achieved an average annual earnings per share of 121.19%. With a float of $97.83 million, this company’s outstanding shares have now reached $98.87 million.
The extent of productivity of a business whose workforce counts for 11000 workers is very important to gauge. In terms of profitability, gross margin is 84.41%, operating margin of -14.91%, and the pretax margin is -13.99%.
BeiGene Ltd. ADR (ONC) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of BeiGene Ltd. ADR is 1.06%, while institutional ownership is 40.42%. The most recent insider transaction that took place on Apr 01 ’25, was worth 14,610,370. In this transaction President, COO & GM China of this company sold 51,921 shares at a rate of $281.40, taking the stock ownership to the 0 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Officer proposed sale 51,921 for $272.17, making the entire transaction worth $14,131,339.
BeiGene Ltd. ADR (ONC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 121.19% per share during the next fiscal year.
BeiGene Ltd. ADR (NASDAQ: ONC) Trading Performance Indicators
BeiGene Ltd. ADR (ONC) is currently performing well based on its current performance indicators. A quick ratio of 1.58 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.13, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach 5.85 in one year’s time.
Technical Analysis of BeiGene Ltd. ADR (ONC)
The latest stats from [BeiGene Ltd. ADR, ONC] show that its last 5-days average volume of 0.65 million was superior to 0.46 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.42%. Additionally, its Average True Range was 11.59.
During the past 100 days, BeiGene Ltd. ADR’s (ONC) raw stochastic average was set at 57.76%, which indicates a significant increase from 1.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.72% in the past 14 days, which was higher than the 47.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $246.70, while its 200-day Moving Average is $204.39. Now, the first resistance to watch is $248.93. This is followed by the second major resistance level at $259.34. The third major resistance level sits at $264.88. If the price goes on to break the first support level at $232.98, it is likely to go to the next support level at $227.44. The third support level lies at $217.03 if the price breaches the second support level.
BeiGene Ltd. ADR (NASDAQ: ONC) Key Stats
Market capitalization of the company is 23.58 billion based on 98,685K outstanding shares. Right now, sales total 3,810 M and income totals -644,790 K. The company made 1,128 M in profit during its latest quarter, and -151,880 K in sales during its previous quarter.
